Central actions of atrial natriuretic polypeptides in spontaneously hypertensive and normotensive rats. 1987

H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
Department of Medicine, Kyoto University School of Medicine, Japan.

The effects of intracerebroventricular (i.c.v.) administration of ANP on blood pressure and intakes of water and salt were examined, using conscious, unrestrained normotensive Wistar rats and spontaneously hypertensive rats (SHR). In normotensive rats, i.c.v. administration of alpha-rat ANP (alpha-rANP), alpha-human ANP (alpha-hANP), alpha-rANP (4-28) and alpha-rANP (5-28) at the dose of 1.5 nmol significantly attenuated water intake induced by i.c.v. injection of 0.1 nmol of angiotensin II (AII). Centrally administered alpha-hANP (5 micrograms) also attenuated AII-induced pressor response. Centrally injected alpha-hANP (1 microgram) produced a greater reduction of water intake after 24-hour water deprivation in SHR compared to control Wistar Kyoto rats (WKY). Central infusion of alpha-hANP for 1 week also reduced the salt appetite of SHR, as shown by two bottle preference test with 0.3 M NaCl solution and tap water, while it had no effect on drinking behavior of WKY. These results suggest the central antagonistic relationship of the ANP and renin-angiotensin systems and the possible involvement of brain ANP in the pathophysiology of genetically hypertensive rats.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011921 Rats, Inbred WKY A strain of Rattus norvegicus used as a normotensive control for the spontaneous hypertensive rats (SHR). Rats, Wistar Kyoto,Wistar Kyoto Rat,Rats, WKY,Inbred WKY Rat,Inbred WKY Rats,Kyoto Rat, Wistar,Rat, Inbred WKY,Rat, WKY,Rat, Wistar Kyoto,WKY Rat,WKY Rat, Inbred,WKY Rats,WKY Rats, Inbred,Wistar Kyoto Rats
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004326 Drinking The consumption of liquids. Water Consumption,Water Intake,Drinkings
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001066 Appetite Natural recurring desire for food. Alterations may be induced by APPETITE DEPRESSANTS or APPETITE STIMULANTS. Appetite Alterations,Alteration, Appetite,Alterations, Appetite,Appetite Alteration,Appetites

Related Publications

H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
October 1988, Acta physiologica Scandinavica,
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
September 1979, Acta physiologica Scandinavica,
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
June 1994, Hypertension (Dallas, Tex. : 1979),
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
January 1985, Hypertension (Dallas, Tex. : 1979),
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
January 1991, Fundamental & clinical pharmacology,
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
June 1989, Hypertension (Dallas, Tex. : 1979),
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
September 1992, Cardiovascular research,
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
March 2003, Bulletin of experimental biology and medicine,
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
November 2005, Clinical and experimental hypertension (New York, N.Y. : 1993),
H Itoh, and K Nakao, and N Morii, and A Sugawara, and T Yamada, and S Shiono, and Y Saito, and M Mukoyama, and H Arai, and M Sakamoto
December 1980, Clinical science (London, England : 1979),
Copied contents to your clipboard!